Cite
MLA Citation
Philippe Moreau et al.. “Isatuximab, carfilzomib, and dexamethasone in relapsed multiple myeloma (IKEMA): a multicentre, open-label, randomised phase 3 trial.” Lancet, vol. 397, no. 10292, 2021, pp. 2361–2371. http://access.bl.uk/ark:/81055/vdc_100133383828.0x000056